1. Home
  2. AENT vs FHTX Comparison

AENT vs FHTX Comparison

Compare AENT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Entertainment Holding Corporation

AENT

Alliance Entertainment Holding Corporation

HOLD

Current Price

$7.10

Market Cap

392.4M

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$5.69

Market Cap

360.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AENT
FHTX
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.4M
360.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AENT
FHTX
Price
$7.10
$5.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$10.00
$11.43
AVG Volume (30 Days)
61.0K
204.4K
Earning Date
02-12-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
131.70
N/A
EPS
0.38
N/A
Revenue
$1,088,441,000.00
$24,518,000.00
Revenue This Year
$8.23
$40.91
Revenue Next Year
$2.26
$11.87
P/E Ratio
$16.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$2.95
52 Week High
$8.80
$6.95

Technical Indicators

Market Signals
Indicator
AENT
FHTX
Relative Strength Index (RSI) N/A 47.69
Support Level N/A $5.18
Resistance Level N/A $5.79
Average True Range (ATR) 0.00 0.34
MACD 0.00 -0.10
Stochastic Oscillator 0.00 27.15

Price Performance

Historical Comparison
AENT
FHTX

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world. The company has two divisions: Alliance Home Entertainment, which offers full-service support across production, marketing, and retail execution. and Alliance Authentic, which focuses on licensed collectibles and branded merchandise, including partnerships with Handmade by Robots, Master Replicas, and Weta Workshop.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: